Archives of the
Turkish Society of Cardiology
Invited review

Clinical effectiveness of ranolazin


Department of Cardiology, Hacettepe University School of Medicine, Ankara, Turkey

Archives of the Turkish Society of Cardiology 2016; 44: Supplement S13-S18
DOI: 10.5543/tkda.2016.84827
Read: 344 Downloads: 38 Published: 24 September 2021

Despite currently prevalent medical, and interventional treatment methods ischemia still continues to be an important health problem. Inhibition of late sodium current into cells has emerged as a new target in the treatment of ischemia, and ranozolin is the most important drug developed to this end. Ranozolin which displays its antianginal effect without effecting heart rate, and blood pressure is recommended as a treatment alternative with proved efficancy in addition to conventional treatment. In this paper, we have attempted to summarize clinical studies which investigated effectiveness of ranozolin.

ISSN 1016-5169 EISSN 1308-4488